State Board of Administration of Florida Retirement System’s Mirum Pharmaceuticals MIRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57M Buy
13,400
+5,453
+69% +$547K ﹤0.01% 1152
2026
Q1
$734K Hold
7,947
﹤0.01% 1380
2025
Q4
$628K Hold
7,947
﹤0.01% 1431
2025
Q3
$583K Hold
7,947
﹤0.01% 1464
2025
Q2
$404K Hold
7,947
﹤0.01% 1623
2025
Q1
$358K Hold
7,947
﹤0.01% 1640
2024
Q4
$329K Hold
7,947
﹤0.01% 1716
2024
Q3
$310K Hold
7,947
﹤0.01% 1787
2024
Q2
$272K Buy
+7,947
New +$208K ﹤0.01% 1813
2024
Q1
Sell
-7,947
Closed -$235K 2330
2023
Q4
$235K Hold
7,947
﹤0.01% 2011
2023
Q3
$251K Buy
+7,947
New +$218K ﹤0.01% 1937

Other funds holding MIRM

State Board of Administration of Florida Retirement System's MIRM Position: Q2 2026 in Review

State Board of Administration of Florida Retirement System increased its Mirum Pharmaceuticals (MIRM) stake by 69% in Q2 2026, buying an estimated $547K and bringing the position to 13,400 shares worth $1.57M. The position accounts for ﹤0.01% of the portfolio, ranked #1152.

State Board of Administration of Florida Retirement System first reported a position in MIRM in Q3 2023 and has held it in 11 quarters since. 144 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • State Board of Administration of Florida Retirement System held 13,400 shares of Mirum Pharmaceuticals worth $1.57M as of Q2 2026.
  • State Board of Administration of Florida Retirement System bought 5,453 Mirum Pharmaceuticals shares in Q2 2026, an estimated $547K.
  • Mirum Pharmaceuticals made up ﹤0.01% of State Board of Administration of Florida Retirement System's portfolio in Q2 2026, its #1152 holding.
  • State Board of Administration of Florida Retirement System first reported a position in Mirum Pharmaceuticals in Q3 2023 and has held it in 11 quarters since.
  • 144 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2026, filed 10 Aug 2026.